EUVIMEDEUVIMED entdecken
Crossref

Disrupting galectin-3 and NET-mediated microglia-neutrophil cross-talk suppresses pathological retinal angiogenesis

Ziyi Zhou iD, Tianhao Yuan iD, Jiaxing Sun iD, Chaowei Tian iD, Guoheng Zhang, Yifan Fang iD, Yuan Chen iD, Yixuan Xi iD, Jiayi Kong, Xiaojia Sun, Tianfang Chang, Zifeng Zhang und 3 weitere

Science Translational Medicine · 05.08.2026 · 18 (861)

DOI: 10.1126/scitranslmed.aea5661 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 05.08.2026. Verfasst von Ziyi Zhou und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China. Hauptthemen laut MEDLINE: Microglia, Retinal Neovascularization, Galectin 3, Neutrophils. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, National key R&D program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current research on pathological retinal neovascularization primarily focuses on growth factors, inflammation, and endothelial signaling pathways. However, increasing attention is being directed toward disruptions in the retinal immune microenvironment. Therefore, deciphering the immune-angiogenic interplay could uncover therapeutic avenues for neovascular disorders. Through integrative analyses of single-cell RNA sequencing from human fibrovascular membranes and multicohort clinical datasets, we identified neutrophil infiltration as an independent risk factor for diabetic retinopathy progression. Mechanistically, activated microglia preceded and potentiated neutrophil infiltration by secreting galectin-3 (GAL3), establishing a self-amplifying feedback loop that sustained microglial activation and drove pathological angiogenesis in mice with oxygen-induced retinopathy (OIR). To therapeutically disrupt this loop, we engineered a photocurable hydrogel for the sustained intravitreal delivery of GAL3 and vascular endothelial growth factor (VEGF)–neutralizing antibodies, which effectively suppressed aberrant angiogenesis in mice with OIR. Together, these findings reinforce the concept of retinal neovascularization as an immunovascular disorder and underscore the therapeutic potential of microenvironment-modulating strategies using biomaterials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaRetinal NeovascularizationGalectin 3NeutrophilsAnimalsHumansVascular Endothelial Growth Factor AMiceDiabetic RetinopathyMice, Inbred C57BLOxygenNeovascularization, Pathologic

Substanzen

Galectin 3Vascular Endothelial Growth Factor AOxygen

Autor:innen und Institutionen

  • Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
  • State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University and Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China.

ORCID-Profile: Ziyi Zhou, Tianhao Yuan, Jiaxing Sun, Chaowei Tian, Yifan Fang, Yuan Chen, Yixuan Xi, Xuri Li, Yusheng Wang, Guorui Dou

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • National key R&D program of China
  • Natural Science Basic Research Program of Shaanxi
  • Shaanxi Innovation Capability Support Program
  • Outstanding Young Talent Fund for Defense Biotechnology
  • Independent research projects for high-level scientific and technological innovation talents of the Military
  • Cross-fusion Special Project of AFMU of AFMU

Zitieren

APA

Zhou, Z., Yuan, T., Sun, J., Tian, C., Zhang, G., Fang, Y., Chen, Y., Xi, Y., Kong, J., Sun, X., Chang, T., Zhang, Z., Li, X., Wang, Y., & Dou, G. (2026). Disrupting galectin-3 and NET-mediated microglia-neutrophil cross-talk suppresses pathological retinal angiogenesis. Science Translational Medicine, 18(861). https://doi.org/10.1126/scitranslmed.aea5661

Vancouver

Zhou Z, Yuan T, Sun J, Tian C, Zhang G, Fang Y, et al. Disrupting galectin-3 and NET-mediated microglia-neutrophil cross-talk suppresses pathological retinal angiogenesis. Science Translational Medicine. 2026;18(861). doi:10.1126/scitranslmed.aea5661

BibTeX
@article{Zhou2026,
  author = {Zhou, Ziyi and Yuan, Tianhao and Sun, Jiaxing and Tian, Chaowei and Zhang, Guoheng and Fang, Yifan and Chen, Yuan and Xi, Yixuan and Kong, Jiayi and Sun, Xiaojia and Chang, Tianfang and Zhang, Zifeng and Li, Xuri and Wang, Yusheng and Dou, Guorui},
  title = {Disrupting galectin-3 and NET-mediated microglia-neutrophil cross-talk suppresses pathological retinal angiogenesis},
  journal = {Science Translational Medicine},
  year = {2026},
  volume = {18},
  number = {861},
  doi = {10.1126/scitranslmed.aea5661}
}
Kostenlos starten →